The role of natural killer (NK) cells in hematopoietic stem cell transplantation and in the control of neonatal infections is not yet clear. Donor-versus-recipient NK cell alloreactivity was found to improve outcome in some settings of hematopoietic stem cell transplantation. We hypothesized that the role of NK cells in cord blood (CB) transplantation and neonatal infections may depend on CB NK cell maturation stage. We therefore analyzed the expression of NK cell differentiation/phenotypic markers in human CB, as well as functional properties of purified CB NK cells. CD8 and CD57 expression was lower in CB than in adult NK cells. However, the expression of other differentiation markers was similar, as was cell surface density of CD56, the percentage of late NK cell precursors, interferon-␥ production, and the proliferative response of purified NK cells to IL-2. Spontaneous cytotoxic activity of purified CB NK cells against NK-sensitive targets was low but reached adult levels after treatment with IL-15. Expression of perforin and granzyme B was higher in CB NK cells (90 versus 58% and 86 versus 69%, respectively Natural killer (NK) cells are innate immune lymphocytes defined by their cell surface expression of the CD56 antigen without expression of the CD3 antigen. They display a broad anti-infectious and antitumor cytolytic activity. They can also secrete various cytokines, such as interferon (IFN)-␥ and other cytokines that regulate the immune response and hematopoiesis (1). Although NK cells play an important role early in the infectious cycle, at a time when specific immunity has not yet fully developed, their role in the defense of the neonate against infection has not been studied (2). It was demonstrated recently that NK cells play an important role in the outcome of clinical HLA-haploidentical hematopoietic stem cell transplantation (1,3). A positive effect of NK cell alloreactivity has also been reported in a series of unrelated hematopoietic stem cell transplantations (4). We, as several other groups, use cord blood (CB) as a source of stem cells in partially HLA-mismatched transplantation with outcomes similar to those observed in HLA-identical bone marrow transplantation (5-9). CB contains a higher percentage of NK cells than adult blood-, bone marrow-, or cytokine-mobilized peripheral blood stem cell grafts (10). It thus is tempting to speculate that neonatal/CB NK cells may play a role in CB transplantation as well as in the control of neonatal infections.
Natural killer (NK) cells are innate immune lymphocytes defined by their cell surface expression of the CD56 antigen without expression of the CD3 antigen. They display a broad anti-infectious and antitumor cytolytic activity. They can also secrete various cytokines, such as interferon (IFN)-␥ and other cytokines that regulate the immune response and hematopoiesis (1) . Although NK cells play an important role early in the infectious cycle, at a time when specific immunity has not yet fully developed, their role in the defense of the neonate against infection has not been studied (2) . It was demonstrated recently that NK cells play an important role in the outcome of clinical HLA-haploidentical hematopoietic stem cell transplantation (1, 3) . A positive effect of NK cell alloreactivity has also been reported in a series of unrelated hematopoietic stem cell transplantations (4) . We, as several other groups, use cord blood (CB) as a source of stem cells in partially HLA-mismatched transplantation with outcomes similar to those observed in HLA-identical bone marrow transplantation (5) (6) (7) (8) (9) . CB contains a higher percentage of NK cells than adult blood-, bone marrow-, or cytokine-mobilized peripheral blood stem cell grafts (10) . It thus is tempting to speculate that neonatal/CB NK cells may play a role in CB transplantation as well as in the control of neonatal infections.
Several markers of NK cell immaturity have been described. Among these is the level of cell-surface expression of CD56. The majority of adult blood NK cells are CD56 dim , whereas a minority (~10%) are CD56 bright (11) . In vitro studies have defined the differentiation stages of NK cell progenitors from bone marrow precursors. From these studies, it was found that terminal maturation leads to cells that resemble phenotypically and functionally the CD56 bright NK cell subset, thus suggesting that CD56 bright cells may be precursors of CD56 dim cells (12, 13) . This is further supported by the fact that CD56 dim cells harbor the attributes of more differentiated cells, such as the need for higher concentrations of IL-2 to proliferate and a potent cytotoxic function (13) (14) (15) . Furthermore, the first NK cells that appear in blood after hematopoietic stem cell transplantation are mainly CD56 bright (16) . Several other characteristics have been shown to be associated with immaturity or high cell surface density of CD56: low expression of CD8, CD16, and CD57; high expression of CD11c and L-selectin (11, 13, 17, 18) ; low expression of killer cell immunoglobulinlike receptors (KIR) and high expression of the CD94/NKG2 family of NK cell receptors (17, 19) ; expression of the highaffinity heterotrimeric IL-2 receptor (IL-2R) ␣␤␥; expansion in response to picomolar doses of IL-2; low cytotoxic activity against NK-sensitive targets; and strong production of cytokines, including IFN-␥ (11, (13) (14) (15) .
Although studies have investigated NK cells derived from CB hematopoietic progenitors after several days of in vitro maturation with various cytokines, data about primary NK cells from CB are scarce. One recent study reported that the expression of adhesion molecules is reduced on CD56 dim CB NK cells (20) . However, this study did not investigate the full range of phenotypic and functional markers of NK cell maturation. In mice, neonatal NK cells express fewer Ly49 receptors than adult NK cells (21) . Ly49 receptors are counterparts of human KIR, the expression of which is lower in immature NK cells (17) . Cytotoxic activity of fresh unfractionated human CB mononuclear cells against NK-sensitive targets has been demonstrated to be lower than in adult, a feature associated with CD56 bright immature cells (22, 23) . These data suggest that CB NK cells are immature. Such an immaturity may interfere with their potential role in CB transplantation and neonatal infections.
We thus undertook a study to examine the differentiation stage of fresh CB NK cells (i.e. without inducing in vitro maturation). To this end, we compared NK cells from CB and adult blood for all of the phenotypic and functional features that have been associated with distinct differentiation stages of human NK cells. We carried out functional studies using purified NK cells to exclude any bystander cell effect. Our data show that CB NK cells display most of the features associated with maturity in current models of NK cell differentiation. In addition, CB NK cells display some unique features, such as high perforin and granzyme B expression and low L-selectin, intercellular adhesion molecule-1 (ICAM-1), and CD161 expression.
METHODS
Collection of blood samples. CB samples were harvested in heparinized tubes by umbilical vein puncture after normal delivery of full-term healthy neonates. Informed written consent, as approved by the local Ethics Committee, was obtained from pregnant women before delivery. Adult peripheral blood samples were obtained from healthy volunteer donors after informed written consent.
NK cell purification. Mononuclear cells were isolated by density gradient centrifugation (Ficoll-Hypaque Plus; Amersham Biosciences, Piscataway, NJ). Cells were cryopreserved in 40% FCS with 10% DMSO. Thawed cells were resuspended in RPMI 1640 with 10% FCS, antibiotics, and L-tyrosine. NK cells were purified from mononuclear cells by negative immunoselection using the StemSep Lineage Depletion kit (StemCell Technologies, Vancouver, BC, Canada), according to the manufacturer's instructions. Briefly, mononuclear cells were incubated for 30 min with an antibody cocktail (anti-CD3, anti-CD4, anti-CD14, anti-CD19, anti-CD66b, and anti-glycophorin A), after which the magnetic colloid was added for an additional 30 min. Cells then were passed through a magnetic column for collection of purified cells. More than 97% of the purified cells were CD3-CD56ϩ, as assessed by flow cytometry (data not shown).
MAb and flow cytometric analysis. Fresh mononuclear cells were stained with anti-CD56-phycoerythrin (PE) or anti-CD56-FITC and anti-CD3-peridin-chlorophyll protein (BD Biosciences, Mississauga, ON, Canada) and one of the following MAbs: anti-CD2-FITC, anti-CD8␣␣-FITC, anti-CD11a-FITC, anti-CD11b-PE, anti-CD11c-PE, anti-CD16-FITC, anti-CD25-FITC, anti-CD50-FITC, anti-CD54-PE, anti-CD57-FITC, anti-CD62L-FITC, anti-CD94-PE, anti-CD122-PE, anti-CD132-FITC, anti-CD158a-FITC, antiCD158b-FITC, anti-CD161-FITC, anti-tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-PE (BD Biosciences), anti-CD102-FITC (Serotec, Raleigh, NC), or anti-Fas ligand (Fas-L)-PE (Caltag; Cedarlane Laboratories, Hornby, ON, Canada). For intracellular staining, mononuclear cells were first surface-stained with the same anti-CD3 and anti-CD56 antibodies, permeabilized using the Fix/Perm cell permeabilization kit (BD Biosciences), and then stained with anti-perforin-FITC (BD Biosciences) or anti-granzyme B-PE (Caltag). Cells were subsequently analyzed on a FACScan flow cytometer (BD Biosciences) using the CellQuest software.
51 Cr release assay. Cytotoxicity was assessed using a 51 Cr release assay (24) . Briefly, 10 6 K562 target cells were labeled with 100 Ci of Na 2 51 CrO 4 for 45 min at 37°C. Mononuclear cells or purified NK cells were washed twice with PBS and resuspended in culture medium. Ten thousand cells were distributed per well in a 100-L volume, with or without 50 ng/mL IL-15 (Immunex, Seattle, WA). Effector cells were added in an equal volume for a 10:1 E:T ratio in triplicate and incubated at 37°C for 16 h. Supernatants were assessed for 51 Cr release using a ␥-counter. Culture medium or 1 M HCl was added to labeled target cells for calculation of spontaneous or maximum release, respectively. The percentage of specific 51 Cr release was calculated as follows: (cpm experimental release Ϫ cpm spontaneous release)/(cpm maximal release Ϫ cpm spontaneous release) ϫ 100. The ratio of spontaneous release to maximal release was Ͻ0.2 in all experiments.
Intracellular cytokine detection. Mononuclear or purified NK cells were incubated (10 6 /mL, 6 h, 37°C) in medium with or without phorbol myristate acetate (10 Ϫ9 M) and Ca 2ϩ ionophore (A23187, 0.1 g/mL; all reagents were from Sigma Chemical Co.-Aldrich, St. Louis, MO). Brefeldin A (Sigma Chemical Co.-Aldrich; 10 g/mL) was added during the last 5 h. Cells were fixed and permeabilized using the Fix/Perm cell permeabilization kit (BD Biosciences) for 10 min at room temperature. Cells then were stained with an anti-IFN-␥-FITC MAb (BD Biosciences), washed, and analyzed by flow cytometry.
Cell proliferation studies. Mononuclear cells or purified NK cells were labeled with CFSE (Molecular Probes, Eugene, OR) as reported (25) but with minor modifications. Briefly, cells were resuspended at 10 7 /mL in PBS-0.1% BSA and labeled with 2 M CFSE for 10 min at room temperature in the dark. Cells were washed twice in PBS-0.1% BSA and once in complete culture medium. Cell recovery and viability, as assessed by trypan blue dye exclusion, were consistently Ͼ95%. Cells then were plated at a concentration of 10 6 /mL in wells of a 96-well plate and incubated in the absence or presence of IL-2 (2 ϫ 10 6 U/mg specific activity; Roche, Indianapolis, IN) at 0.1 (3 pM), 1 (30 pM), and 10 UI/mL (0.3 nM) for 7 d. After incubation, cells were washed three times in PBS and analyzed by flow cytometry.
Definitions and statistical analysis. For flow cytometric studies, lymphocytes were defined as cells that were positive for at least one of the following markers: CD3, CD19, or CD56. NK cells were defined as CD3 Ϫ CD56 ϩ cells. The percentage of cells that expressed a marker was described by its median expression on separate experiments from different adult blood or CB samples. Statistical comparison between marker expression was performed using the nonparametric Mann-Whitney test, using GraphPad Prism 3.00 for Windows (GraphPad Software, San Diego, CA). In this setting of multiple comparisons, ␣ ϭ 0.01 was used as a threshold of significance. 1C) . Similarly, the percentage of CD16
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NK cell precursors and subsets in CB.
Ϫ cells was 18% among CB and 29% among adult blood NK cells (p ϭ 0.08; Fig. 1C ).
We then investigated other features attributed to less differentiated NK cells: no cell surface expression of CD8, CD57, KIR CD158a, and KIR CD158b and cell surface expression of CD11c, L-selectin (CD62L), and CD94 ( Fig. 2) (11, 13, (17) (18) (19) . There was no difference in the percentage of NK cells that expressed the NK-specific receptors CD94, KIR CD158a, or KIR CD158b or the CD11c surface antigen (Fig. 2) . The percentage of NK cells that expressed CD8 and CD57 was lower in CB than in adult blood [30 versus 62% for CD8 (p ϭ 0.009) and 10 versus 51% for CD57 (p ϭ 0.0003); Fig. 2] . However, the percentage of L-selectin-positive NK cells, considered to represent an immature phenotype, was also significantly lower in CB (9.8 versus 23%; p Ͻ 0.0001; Fig. 2 ).
To have a more complete picture of the phenotypic characteristics of CB NK cells, we investigated the expression of other activating and adhesion molecules: CD2, LFA-1␣ (CD11a), Mac-1␣ (CD11b), NKRP-1A (CD161), ICAM-1 (CD54), ICAM-2 (CD102), and ICAM-3 (CD50). The percentage of NK cells that expressed CD2, CD11a, CD11b, ICAM-2, and ICAM-3 was not significantly different among CB an adult blood NK cells (Fig. 2) . Fewer CB NK cells expressed ICAM-1 (36.3 versus 99.5%; p ϭ 0.007; Fig. 2) . CD161, an NK-specific activating molecule, was also expressed by a lower percentage of CB NK cells (1.2 versus 3.9%; p ϭ 0.005; Fig. 2) .
IL-2R expression and proliferation in response to IL-2. High-affinity IL-2R␣␤␥ receptor expression has been associated with a less differentiated NK cell population (14, 15) . We thus investigated the expression of IL-2R subunits. IL-2R␣(CD25)-expressing NK cells were as scarce in CB as in adult blood (median, 1.7 versus 2.9%; Fig. 3A) . Almost all NK cells expressed IL-2R␤ (CD122) in CB as well as in adult blood. IL-2R␥ (CD132) was expressed by almost all adult NK cells (98%). IL-2R␥ expression by CB NK cells was highly variable from one individual to another, with a median of 60% (p ϭ 0.03; Fig. 3A ). Taken together, these results indicate that very few CB and adult NK cells express the high-affinity IL-2R␣␤␥ receptor.
Mononuclear cell and NK cell proliferation in the presence of various amounts of IL-2 was assessed by CFSE staining. In agreement with previous studies showing the presence of cells in cycling phase in CB (27) , unfractionated CB mononuclear cells proliferated in the absence of IL-2 (data not shown). Response to IL-2 thus was compared between three CB and adult blood samples after purification of NK cells by negative immunomagnetic selection. There was no difference between Cytotoxicity pathways and cytolytic activity. Lower cytolytic activity is associated with NK cell immaturity (11-13). We determined the percentage of NK cells that expressed molecules associated with different pathways of cytotoxicity by flow cytometry: intracellular granzyme B and perforin, surface Fas-L, and TRAIL. There was no difference between CB and adult blood NK cells for Fas-L and TRAIL expression. However, intracellular granzyme B and perforin expression was higher in CB NK cells [86 versus 69% for granzyme B (p ϭ 0.01) and 90 versus 58% for perforin expression (p ϭ 0.008); Fig. 4A ).
Spontaneous cytolytic activity of unfractionated mononuclear cells against K562 targets was lower in CB than in adult blood (Fig. 4B) , as already reported (28) . We then studied the cytolytic activity of purified NK cells to exclude any effect of bystander cells (22, 23) . Spontaneous cytotoxicity of purified NK cells against K562 cells was also lower in CB (mean of 51 Cr release at E:T ratio 10:1; 13 versus 60%; Fig. 4B ). There was no such difference when the cells were incubated with 50 ng/mL IL-15 (62 versus 67%; Fig. 4B ).
IFN-␥ production. High IFN-␥ secretion upon stimulation has also been associated with NK cell immaturity (11, 12) . The percentage of cells that produced IFN-␥ upon stimulation with phorbol esters and ionomycin was measured by intracellular staining of unfractionated mononuclear cells and purified NK cells from three adult blood and three CB samples. The percentage of mononuclear cells that produced IFN-␥ upon stimulation was 11% in CB versus 20% in adult blood (Fig. 5) . However, the percentage of purified NK cells that produced IFN-␥ was similar in CB and adult blood (65 versus 77%; Fig.  5 ).
DISCUSSION
Here, we provide evidence that, unlike their neonatal murine counterparts, human CB NK cells express levels of KIR inhibitory receptors similar to those in adults. CB NK cells display some specific features that differ from adult NK cells, some of which have been associated with a less mature stage of differentiation, i.e. lower expression of CD8 and CD57 cell surface molecules and lower spontaneous cytotoxicity against the NKsensitive K562 target (11, 13, 19) . However, cytotoxicity after incubation with IL-15 was similar, and percentages of NK cells that expressed perforin and granzyme B, proteins that are essential for cytotoxicity, were higher in CB NK cells. Lselectin expression has been associated with immature NK cells (17, 18) . It is interesting that very few CB NK cells were found to express L-selectin. The percentage of late NK cell precursors (CD3 
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In most previous reports, the functional properties of CB NK cells were studied using unfractionated mononuclear cells (22, 23, 28) . The differences between CB and adult blood observed in these reports may not be related to specific properties of CB NK cells but rather to modulation by other cells, such as IL-12-and IL-15-producing monocytes (22, 29) . Two studies using purified NK cells reported only spontaneous cytotoxicity of CD3 Ϫ cells, CD16 ϩ CD56 ϩ cells, and CD56 dim and CD56 bright subpopulations obtained by positive selection or complement-based negative selection (20, 30) . To our knowledge, our study is the first to investigate proliferation, IFN-␥ production, and cytotoxicity of CB CD3 Ϫ
CD56
ϩ cells purified by negative selection. In this study, NK cells were purified by negative immunomagnetic selection to prevent any NK cell activation before experiments were undertaken, and a purity Ͼ97% was obtained. In agreement with previous reports (20, 22, 23, 28) , the spontaneous cytotoxic activity of CB mononuclear cells against NK-sensitive targets is lower than that of adult mononuclear cells. Our data show that the cytolytic activity of purified CB NK cells is also lower, suggesting that the difference in cytotoxic activity against NK-sensitive targets between CB and adult blood may be attributed to intrinsic differences in NK cells themselves.
This lower cytolytic activity contrasts with a higher percentage of CB NK cells constitutively expressing perforin and granzyme B. It is interesting that cytotoxic activity was rapidly restored by incubation with IL-15, confirming that the cytotoxic potential of CB NK cells is comparable to that of adult NK cells. It has also been reported that enhancement of cytotoxic activity against NK-sensitive targets by IL-12 is more pronounced in CB than in adult mononuclear cells (31) . Our data suggest that the lower spontaneous cytotoxic activity of CB NK cells may be related to a lower expression of some adhesion and activating molecules, such as ICAM-1 and CD161, rather than to a defect in the cytotoxic machinery. It has been shown that the percentage of CD16 ϩ ICAM-1 ϩ cells is dramatically increased after culture of CB but not adult mononuclear cells with IL-12 or IL-15 (32) . Taken together, these data suggest that the rapid and dramatic effect of IL-12 and IL-15 on CB NK cell cytotoxicity is associated with an up-regulation of adhesion molecules such as ICAM-1, rather than with cell maturation.
Several hypotheses may explain the few differences noted between CB and adult NK cells. First, CB NK cells may be immature. However, our data show that human CB NK cells display almost all features associated with maturity in current models of NK cell maturation (12) . Second, CB NK cells are less likely to have been exposed to immune or inflammatory reactions. Because the production of monocyte-derived cytokines such as IL-12 and IL-15 is decreased in CB, CB NK cells are also less likely to have been exposed to those cytokines (22, 29) . Third, subsets of NK cells expressing high levels of adhesion and homing molecules such as L-selectin and ICAM-1 may have selectively migrated to the placental or fetal tissues during pregnancy or labor, leaving in the blood stream NK cells with a lower expression of these molecules. Fourth, some subsets of NK cells may expand as a consequence of pregnancy or labor. Particularly, CB NK cells are taken from the placenta, the maternal side of which is characterized by the presence in high numbers of decidual NK cells exhibiting specific properties (33) . Exposure to the same cytokines might lead fetal NK cells to share some properties with decidual NK cells. In this regard, it has been reported that decidual NK cells express low levels of L-selectin and display a low level of cytotoxicity against NK-sensitive targets despite normal granzyme B and perforin expression (33) . This low cytotoxic activity is restored by incubation with IL-15. (J. Strominger, personal communication).
A previous study showed that the total amount of IFN-␥ production by mononuclear cells was lower in CB, both spontaneously and after stimulation (22) . We have investigated the percentage of cells that are able to produce IFN-␥ upon stimulation using mononuclear cells as well as purified NK cells. The percentage of IFN-␥-producing cells was similar among purified NK cells from CB and adult blood samples, but a lower percentage of CB unfractionated mononuclear cells produced IFN-␥ (11 versus 20% in adults). It has been demonstrated that IFN-␥ production is decreased in CB T cells and that the IFN-␥ promoter is hypermethylated in CD4 ϩ T cells but not in NK CB cells (34) . The difference in IFN-␥ production between CB and adult blood unfractionated mononuclear cells thus might be due to a lower IFN-␥ production by CB T cells, not by CB NK cells.
Graft-versus-host disease (GVHD) is less frequent after CB transplantation than after bone marrow or peripheral blood stem cell transplantation (6 -9) . It has been postulated that this lower rate of GVHD is due to intrinsic features of neonatal T cells, referred to as T cell immaturity. However, human fetuses are able to mount an adult-like T cell response (35) . Similarly, the high rate of engraftment after CB transplantation despite a low stem cell dose is not fully explained. It was shown recently that absence of NK cell inhibition by hematopoietic host cells decreases GVHD rate and improves engraftment in some series of adult stem cell transplantation (3, 4) . NK cells are the first lymphocytes to recover after CB transplantation, as early as 1 mo posttransplant (36 -38) . We show that CB NK cell properties are not strikingly different from those of adult NK cells, supporting the hypothesis that CB NK cells may have a role to play in CB transplantation. Further studies nevertheless are required to fully appreciate the exact role of donor-derived NK cells in CB transplantation.
Neonates are more susceptible to infections than adults, and neonatal infection carries a high risk for fatal outcome. Profound functional impairment has been reported for most of the components of the immune system. Serum complement activity is reduced (39) . Polymorphonuclear neutrophil production and chemotaxis is impaired (40) . T cells exhibit more frequently a naive phenotype and produce less IL-2, IFN-␥, and IL-4 (41) . Neonatal B cells do not proliferate in response to B cell receptor engagement, and neonates fail to make an antibody response to polysaccharide antigens (41) . The production of monocyte-derived cytokines such as IL-12 and IL-15 is decreased in CB (22, 29) . We showed here that the reduced cytotoxic activity against NK-sensitive targets reported for unfractionated mononuclear cells is also observed after isolation of NK cells. However, normal proliferative potential and 653 normal IFN-␥ production, associated with high expression of perforin and granzyme B, and correction of cytotoxic impairment by treatment with IL-15 suggest that, in contrast with other immune cells, the functional potential of neonatal NK cells is not impaired. Several approaches of immunotherapy have been used in the prophylaxis and treatment of neonatal infections, including i.v. Igs, granulocyte transfusion, and hematopoietic growth factors (42) . The clinical benefit of these approaches has not been proved conclusively thus far. Designing new approaches of immunotherapy for neonatal infection may take advantage of the characteristics of neonatal NK cells. We showed earlier that IL-15 plays a predominant role in NK cell activation by Candida albicans, Escherichia coli, Staphylococcus aureus, respiratory syncytial virus, and herpes simplex virus, five pathogens that are involved in neonatal infections (24, 43) . In light of these data, therapy with IL-15 might be a reasonable approach to treating neonatal infections.
CONCLUSION
In conclusion, to our knowledge, this is the first study to investigate extensively the phenotypic and functional characteristics of purified CB NK cells. Although the spontaneous cytolytic activity of CB NK cells in the 51 Cr release assay is lower than that of adult NK cells, purified CB NK cells were found to harbor a full potential for cytotoxicity, proliferation, and IFN-␥ production. Our data do not support the hypothesis that the difference in NK cell characteristics plays a role in the susceptibility of the newborns to infections. Considering their rapid reconstitution after CB transplantation, our data suggest that CB NK cells may play a role in the success of CB transplantation and may be used as effectors in future studies of immunotherapy in CB transplantation and neonatal infections.
